About Immunai
Immunai maps the immune system using single-cell genomics and machine learning. It offers an operating system with solutions for target discovery, preclinical evaluation, and clinical trial optimization. Its customers are biopharmaceutical companies and research institutions.
Company Details
Corporate & Operational Profile
Web & Domain Identity
Social & Network Presence
Company Milestones & Timeline
- Capital Raise
Raised $215,000,000 · Series-B+
startupintros.com
- Capital Raise
Raised $60,000,000 · Series-A
startupintros.com
- Capital Raise
Raised $20,000,000 · Seed
startupintros.com
- Milestone
X account created (@Immunaitech)
1.2K followers
- Milestone
Company founded
New York, United States
- Milestone
Website domain registered
immunai.com
Investors & Backers
Funding History
Founders & Leadership
Ansuman Satpathy
Co-Founder
Dan Littman
Founder
Previously / Related: Vedanta Biosciences
Danny Wells
Founder
Luis F Voloch
Co-Founder
Mark Jacobstein
Chief Business Officer
Noam Solomon
CEO & Co-Founder
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Hexagon Bio
hexagonbio.com
RefloDx
reflodx.com
HeyVoli
heyvoli.com
CureBay
curebay.com
4Tissue
4tissue.com